| pubmed-article:10802765 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10802765 | lifeskim:mentions | umls-concept:C0014544 | lld:lifeskim |
| pubmed-article:10802765 | lifeskim:mentions | umls-concept:C0228174 | lld:lifeskim |
| pubmed-article:10802765 | lifeskim:mentions | umls-concept:C0017725 | lld:lifeskim |
| pubmed-article:10802765 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:10802765 | lifeskim:mentions | umls-concept:C0009830 | lld:lifeskim |
| pubmed-article:10802765 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:10802765 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:10802765 | pubmed:dateCreated | 2000-5-23 | lld:pubmed |
| pubmed-article:10802765 | pubmed:abstractText | Positron emission tomography (PET) using 18F-radiolabeled deoxyglucose (18F-FDG) is a sensitive procedure for detection of epileptogenic foci. Although alterations in glucose consumption are not restricted to the area of seizure generation itself, the magnitude and extent of cerebral metabolic disturbances induced by epileptic discharges can be detected. Despite two decades of epilepsy research using 18F-FDG-PET, little is known about the metabolic changes during therapy of focal epilepsy. We report on a child with frontal epilepsy with severe glucose hypometabolism that was nearly completely normalized during drug therapy. | lld:pubmed |
| pubmed-article:10802765 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10802765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10802765 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10802765 | pubmed:month | May | lld:pubmed |
| pubmed-article:10802765 | pubmed:issn | 0013-9580 | lld:pubmed |
| pubmed-article:10802765 | pubmed:author | pubmed-author:SchoberOO | lld:pubmed |
| pubmed-article:10802765 | pubmed:author | pubmed-author:SchuiererGG | lld:pubmed |
| pubmed-article:10802765 | pubmed:author | pubmed-author:KurlemannGG | lld:pubmed |
| pubmed-article:10802765 | pubmed:author | pubmed-author:MathejaPP | lld:pubmed |
| pubmed-article:10802765 | pubmed:author | pubmed-author:LöttgenJJ | lld:pubmed |
| pubmed-article:10802765 | pubmed:author | pubmed-author:WeckesserMM | lld:pubmed |
| pubmed-article:10802765 | pubmed:author | pubmed-author:DebusOO | lld:pubmed |
| pubmed-article:10802765 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10802765 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:10802765 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10802765 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10802765 | pubmed:pagination | 588-93 | lld:pubmed |
| pubmed-article:10802765 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:meshHeading | pubmed-meshheading:10802765... | lld:pubmed |
| pubmed-article:10802765 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10802765 | pubmed:articleTitle | Drug-induced changes in cerebral glucose consumption in bifrontal epilepsy. | lld:pubmed |
| pubmed-article:10802765 | pubmed:affiliation | Department of Nuclear Medicine, University of Münster, Münster, Germany. matheja@uni-muenster.de | lld:pubmed |
| pubmed-article:10802765 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10802765 | pubmed:publicationType | Case Reports | lld:pubmed |
